Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University462 Ruijin Hospital282 Shanghai Zhongshan Hospital169 RenJi Hospital133 Children's Hospital of Fudan University84
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Shanghai

3879 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Ruijin Hospital
Observational
100
Shanghai
2025-02-01
Not yet open
Early Identification and Treatment of Rare Cardiomyopathy Cohorts
NCT06794710Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Metabolic Cardiomyopathy, Restrictive Cardiomyopathy
RenJi Hospital
Not applicable
300
Shanghai
2025-02-01
Recruiting
Beijing Chao Yang Hospital
Not applicable
200
Beijing, Guangzhou, Zhengzhou, Changsha, Shenyang, Shanghai, Taiyuan, Hangzhou
2025-02-01
Not yet open
Chemoradiotherapy in Elderly Patients with Locally Advanced Pancreatic Cancer (70+).
NCT06844773Unresectable Locally Advanced Pancreatic Cancer
Shanghai Zhongshan Hospital
Observational
36
Shanghai
2025-02
Not yet open
Effect of Food and Age on the Pharmacokinetics of LY03017
NCT06793995Alzheimer's Disease Psychosis, Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia
DrugLY03017
Luye Pharma Group Ltd.
Phase 1
26
Shanghai
2025-02
Not yet open
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
90
Beijing, Shanghai
2025-02
Not yet open
Evaluation of an Artificial Intelligence Model for the Prediction of Human Blastocyst Ploidy Without Invasive Procedures
NCT06762704The Focus is to Validate the Accuracy of a Non-invasive Artificial Intelligence Model for the Prediction of the Human Blastocyst Ploidy, Preimplantation Genetic Testing (PGT)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,408
Hefei, Nanjing, Nanchang, Xi'an, Shanghai
2025-02
Not yet open
Identification of Pathogenic Bacteria of Diabetes Foot Ulcer
NCT06777810Diabetic Foot Disease, Diabetic Foot Ulcer, Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2025-01-31
Recruiting
Shanghai Chest Hospital
Observational
50
Shanghai
2025-01-30
Not yet open
Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC
NCT06768255Abiraterone Acetate, MCRPC (metastatic Castration-resistant Prostate Cancer)
DrugsAbiraterone acetate·Prednisolone
Ding-Wei Ye
Phase 3
400
Shanghai
2025-01-30
Active, closed
FINEPKT - Finerenone in Proteinuria Patients After Kidney Transplan
NCT07356388Kidney Transplantation Recipients, Proteinuria Patients
kewen Chen,MD
Phase 3
54
Shanghai
2025-01-30
Recruiting
Shanghai 6th People's Hospital
Observational
500
Shanghai
2025-01-26
Recruiting
Longbio Pharma
Phase 2
200
Shanghai
2025-01-25
Recruiting
MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL
NCT06793189Marginal Zone Lymphoma(MZL)
DrugOrelabrutinib
Ruijin Hospital
Phase 2
145
Shanghai, Shenyang, Beijing
2025-01-23
Recruiting
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1
30
Shanghai
2025-01-23
Recruiting
Pfizer
Phase 3
211
Hefei, Nanchang, Shanghai, Kunming, Beijing
2025-01-22
Active, closed
Institut de Recherches Internationales Servier
Phase 1/2
51
Beijing, Shanghai
2025-01-22
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
300
Shanghai
2025-01-21
Recruiting
Livzon Pharmaceutical Group Inc.
Phase 2
320
Shanghai
2025-01-20
Active, closed
Bristol-Myers Squibb
Observational
153
Guangzhou, Handan, Dalian, Shanghai, Beijing
2025-01-20
Recruiting
Yifeng Jing
Early Phase 1
30
Shanghai
2025-01-20
Recruiting
Ruijin Hospital
Phase 1
60
Shanghai
2025-01-20
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal
Chinese University of Hong Kong
Observational
375
Guangzhou, Shanghai
2025-01-20
Recruiting
Fudan University
Phase 2
198
Shanghai
2025-01-20
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
136
Shanghai
2025-01-20
Recruiting
A Study of Chinese Congenital Bicuspid Aortic Valve
NCT06802016Bicuspid Aortic Valve (BAV)
Ruijin Hospital
Observational
500
Shanghai
2025-01-18
Recruiting
Fudan University
Observational
1,000,000
Shanghai
2025-01-17
Active, closed
Sinocare
Not applicable
160
Beijing, Chongqing, Shunde, Wuhan, Jinan, Shanghai
2025-01-17
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
DrugEculizumab
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Recruiting
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
NCT06775743NSCLC (Advanced Non-small Cell Lung Cancer), EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
Fudan University
Phase 2
53
Shanghai
2025-01-15
Not yet open
RenJi Hospital
Not applicable
1,976
Shanghai
2025-01-15
Recruiting
Study on the Mechanism of Acquired Resistance of Entrectinib
NCT07199959ROS1 Fusion Positive, Non Small Cell Lung Cancer
DrugEntrectinib
Fudan University
Observational
38
Shanghai
2025-01-15
Recruiting
Luye Pharma Group Ltd.
Phase 1/2
120
Shanghai
2025-01-14
Recruiting
Efficacy and Safety of Spinal Cord Stimulation in Patients With Spinal Cord Stimulation
NCT06515132Disorder of Consciousness, Spinal Cord Stimulation
Huashan Hospital
Not applicable
50
Fuzhou, Changsha, Shanghai
2025-01-10
Active, closed
Tsinghua University
Not applicable
900
Beijing, Shanghai
2025-01-10
Recruiting
AI Models for Cerebral Aneurysms Segmentation, Detection and Stability Prediction
NCT06766422Unruptured Cerebral Aneurysm, Artificial Intelligence (AI), Subarachnoid Hemorrhage, Aneurysmal, Magnetic Resonance Angiography
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
10,000
Shanghai
2025-01-10
Recruiting
Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs
NCT06754956High Resolution Vessel Wall Imaging, Intracranial Atherosclerotic Stenosis, ICAS, Arteriosclerosis
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Not applicable
100
Shanghai
2025-01-10
Recruiting
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
208
Shanghai
2025-01-09
Recruiting
Fudan University
Phase 3
1,388
Shanghai
2025-01-09
Recruiting
Huashan Hospital
Early Phase 1
10
Shanghai
2025-01-09
Recruiting
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
163
Beijing, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Tianjin
2025-01-08
Recruiting
Fudan University
Phase 1/2
74
Shanghai
2025-01-08
Recruiting
Peking University First Hospital
Phase 4
84
Changsha, Jinan, Chengdu, Ürümqi, Wenzhou, Beijing, Shanghai
2025-01-07
Recruiting
Henan Genuine Biotech Co., Ltd.
Phase 1
48
Harbin, Jinan, Shanghai, Xinxiang
2025-01-07
Recruiting
RenJi Hospital
Observational
220
Shanghai
2025-01-06
Recruiting
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
NCT06754371Postpartum Hemorrhage, Systemic Autoimmune Diseases
DrugTranexamic Acid
RenJi Hospital
Phase 4
276
Shanghai
2025-01-06
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Yangzhou, Shanghai, Hangzhou, Huzhou, Jiaxing, Ningbo, Wenzhou
2025-01-06
Active, closed
Daiichi Sankyo
Phase 2
335
Changsha, Shanghai
2025-01-06
Active, closed
Children's Hospital of Fudan University
Observational
1,000
Shanghai
2025-01-05
Recruiting
Pancreatic Cancer and Diabetes Mellitus
NCT06585072Pancreatic Cancer, Surgery, Diabetes Mellitus
Shanghai Changzheng Hospital
Observational
150
Shanghai
2025-01-03
Active, closed
Fudan University
Observational
3,000
Shanghai
2025-01-01
Recruiting
Dupilumab Therapy for EGIDs
NCT07257835Eosinophilic Gastrointestinal Disorders (EGIDs)
Children's Hospital of Fudan University
Observational
20
Shanghai
2025-01-01
Active, closed
O-RADS MRI System on Early Detection of Ovarian Cancer
NCT07009743Ovarian Cancer (OvCa), Ovarian Cancer Metastatic
Shanghai Gynecologic Oncology Group
Observational
2,549
Shanghai
2025-01-01
Recruiting
Ruijin Hospital
Observational
400
Shanghai
2025-01-01
Active, closed
Ruijin Hospital
Observational
120
Shanghai
2025-01-01
Recruiting
Eye & ENT Hospital of Fudan University
Observational
120
Shanghai
2025-01-01
Recruiting
Eastern Hepatobiliary Surgery Hospital
Phase 2
50
Shanghai
2025-01-01
By invitation
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu, Shanghai
2025-01-01
Recruiting
Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial
NCT06965231Melanoma of Skin, Acral Melanoma, Stage II Melanoma
DrugsEndostar·Toripalimab
Fudan University
Phase 2
58
Shanghai
2025-01-01
Recruiting
Sheng Zhang
Phase 2
84
Shanghai
2025-01-01
By invitation
Zou Junjie
Not applicable
120
Shanghai
2025-01-01
Recruiting
Jin Yang
Not applicable
120
Shanghai
2025-01-01
Recruiting
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
15
Shanghai
2025-01-01
Not yet open
Ruijin Hospital
Observational
200
Shanghai
2025-01-01
Active, closed
Shanghai Zhongshan Hospital
Phase 1
3
Shanghai
2025-01-01
Recruiting
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2025-01-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 3
316
Shanghai
2025-01-01
Not yet open
Ruijin Hospital
Phase 2
73
Shanghai
2025-01-01
Not yet open
Shanghai Chest Hospital
Not applicable
600
Shanghai
2025-01-01
Recruiting
Children's Hospital of Fudan University
Not applicable
200
Shanghai
2025-01-01
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
120
Shanghai
2025-01-01
Recruiting
Fudan University
Not applicable
16,000
Shanghai
2025-01-01
Recruiting
Children's Hospital of Fudan University
Phase 4
80
Shanghai
2025-01-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2025-01-01
Recruiting
Trazodone on NREM Sleep Stage Ⅲ in Depressed Insomniac Co-morbid Patients
NCT06740188Depressed Insomniac Co-morbid Patients
Tongji University
Phase 4
60
Shanghai
2025-01-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Not applicable
210
Shanghai
2025-01-01
Recruiting
Fudan University
Phase 2
165
Fuzhou, Shanghai, Tianjin
2025-01-01
Recruiting
Shanghai Mental Health Center
Phase 1/2
15
Shanghai
2025-01-01
By invitation
Shanghai Atrial Fibrillation Registry
NCT06802965Atrial Fibrillation (AF)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
400,000
Shanghai
2025-01-01
Recruiting
A Prospective Cohort Study of ITB Treatment for HSP
NCT06844734Hereditary Spastic Paraplegia
Shanghai 6th People's Hospital
Observational
50
Shanghai
2025-01-01
Recruiting
Jin Yang
Not applicable
400
Shanghai
2025-01-01
Not yet open
RenJi Hospital
Not applicable
10
Shanghai
2025-01
Recruiting
Fudan University
Observational
624
Shanghai
2024-12-31
Recruiting
Ruijin Hospital
Observational
1,500
Shanghai
2024-12-31
Recruiting
Ruijin Hospital
Phase 1
29
Shanghai
2024-12-31
Not yet open
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-31
Recruiting
Changhai Hospital
Phase 1
19
Shanghai
2024-12-31
Recruiting
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
48
Shanghai
2024-12-31
Not yet open
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
29
Shanghai
2024-12-31
Not yet open
Ruijin Hospital
Phase 2
34
Shanghai
2024-12-31
Not yet open
Study of HRS-2189 Combined HRS-5041 in Prostate Cancer
NCT06738745Prostate Cancer Metastatic Disease
DrugsHRS-2189·HRS-5041
Fudan University
Phase 2
90
Shanghai
2024-12-31
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
316
Shanghai
2024-12-31
Active, closed
Fudan University
Observational
197
Shanghai
2024-12-31
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2024-12-30
Recruiting
Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC
NCT06876844Head and Neck Cancer, Head and Neck Cancer Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
24
Shanghai
2024-12-30
Recruiting
Shanghai Changzheng Hospital
Not applicable
16
Shanghai
2024-12-30
Active, closed
Shanghai Dynaheart Medtech Co., Ltd.
Not applicable
254
Jilin City, Shanghai
2024-12-30
Active, closed
Ruijin Hospital
Phase 1/2
10
Shanghai
2024-12-30
Active, closed
Suzhou HepaThera Biotech Co., Ltd.
Phase 1/2
86
Beijing, Xiamen, Guangzhou, Qingyuan, Shanghai, Chengdu
2024-12-30
Recruiting
Aibin Liang，MD，Ph.D.
Phase 1
24
Shanghai
2024-12-30
Not yet open
Shanghai Public Health Clinical Center
Early Phase 1
60
Shanghai
2024-12-30
Recruiting
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
NCT06566079Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor
InSilico Medicine Hong Kong Limited
Phase 1/2
160
Zhengzhou, Shanghai, Beijing, Guangzhou
2024-12-27
Active, closed
Amgen
Phase 2
61
Beijing, Fuzhou, Zhengzhou, Wuhan, Changsha, Changchun, Jinan, Shanghai
2024-12-26
Not yet open
Detachable String Magnetically Controlled Capsule Endoscopy for Patients with AUGIB
NCT06725056Acute Upper Gastrointestinal Bleeding, Capsule Endoscopes
Changhai Hospital
Not applicable
120
Shanghai
2024-12-25
Not yet open
Energenx Medical LTD.
Not applicable
10
Shanghai
2024-12-25
Not yet open
Shanghai Chest Hospital
Not applicable
600
Shanghai
2024-12-25
Not yet open
Fudan University
Phase 2
141
Shanghai
2024-12-25
Recruiting
Energenx Medical LTD.
Not applicable
126
Shanghai
2024-12-25
Recruiting
Total Infectome Characterization of Eye Infections
NCT06775808Eye Infections, Diagnosis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
200
Shanghai
2024-12-25
Recruiting
Shanghai AbelZeta Ltd.
Phase 1
24
Shanghai
2024-12-25
Recruiting
Shanghai Mental Health Center
Not applicable
90
Shanghai
2024-12-24
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
64
Shanghai
2024-12-24
Recruiting
RenJi Hospital
Not applicable
100
Shanghai
2024-12-23
Recruiting
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638Renal Cancer, Renal Clear Cell Carcinoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse
Drug[18F]RCCB6
RenJi Hospital
Phase 2
300
Shanghai
2024-12-23
Recruiting
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT06851663Solid Tumor, Solid Carcinoma, Uroepithelial Carcinoma, Bladder Cancer
Drugs[68Ga]Ga-NOTA-RT4·[18F]F-RESCA-RT4·[18F]F-RESCA-T4·[68Ga]Ga-NOTA-T4
RenJi Hospital
Phase 2/3
400
Shanghai
2024-12-23
Recruiting
Ruijin Hospital
Early Phase 1
66
Wuhan, Nanjing, Shanghai
2024-12-23
By invitation
Shanghai Pulmonary Hospital, Shanghai, China
Observational
308
Shanghai
2024-12-23
Recruiting
Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)
NCT07002398Retinal Dystrophy Due to Biallelic ABCA4 Mutations, Stargardt Disease 1
VeonGen Therapeutics GmbH
Phase 1/2
18
Shanghai
2024-12-23
Not yet open
RenJi Hospital
Not applicable
92
Shanghai
2024-12-20
Recruiting
Eye & ENT Hospital of Fudan University
Early Phase 1
2
Shanghai
2024-12-20
Active, closed
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
225
Shanghai
2024-12-20
Not yet open
Epigenic Therapeutics, Inc
Early Phase 1
20
Shanghai
2024-12-20
Recruiting
Sanofi
Phase 2
84
Beijing, Chengdu, Shanghai
2024-12-19
Active, closed
argenx
Phase 3
154
Shanghai
2024-12-18
Not yet open
Shanghai Chest Hospital
Not applicable
418
Shanghai
2024-12-16
Recruiting
Suzhou Biomissile Pharmaceuticals Co., Ltd.
Phase 1
123
Bengbu, Shanghai, Hangzhou
2024-12-16
Not yet open
Shanghai Chest Hospital
Not applicable
304
Shanghai
2024-12-16
Recruiting
GlaxoSmithKline
Phase 3
520
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai
2024-12-16
Active, closed
Shanghai JMT-Bio Inc.
Phase 3
520
Shanghai
2024-12-16
Recruiting
Evaluation of a CAM System for Colorectal Polyp Size Measurement
NCT06715384Colorectal Polyp, Colorectal Adenoma
Changhai Hospital
Not applicable
168
Shanghai
2024-12-15
Not yet open
Shanghai Chest Hospital
Phase 1/2
30
Shanghai
2024-12-15
Recruiting
Shanghai Mental Health Center
Not applicable
60
Guangzhou, Shijiazhuang, Xinxiang, Nanchang, Taiyuan, Mianyang, Shanghai, Tianjin
2024-12-14
Active, closed
Shanghai Vitalgen BioPharma Co., Ltd.
Phase 3
45
Shanghai
2024-12-13
Recruiting
Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma
NCT06781567Adenoid Cystic Carcinoma, Head and Neck Cancer
HitGen Inc.
Phase 2
140
Shanghai
2024-12-13
Recruiting
Shanghai Cell Therapy Group Co.,Ltd
Early Phase 1
12
Shanghai
2024-12-12
Recruiting
GlaxoSmithKline
Phase 3
514
Beijing, Chengdu, Hangzhou, Mianyang, Shanghai, Shenyang, Zhuzhou
2024-12-12
Recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 4
60
Shanghai
2024-12-12
Recruiting
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
NCT06730321Thyroid Cancer, Thyroid Nodule, Thyroid Diseases, Thyroid Cancer, Papillary
Shanghai 6th People's Hospital
Observational
200
Shanghai
2024-12-12
Recruiting
Sun Yat-Sen University Cancer Center
Phase 1/2
10
Guangzhou, Dongguan, Shanghai
2024-12-12
Recruiting
a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
NCT06718270Relapsed/Refractory Multiple Myeloma, Relapsed/Refractory Plasma Cell Leukemia
Shanghai Changzheng Hospital
Early Phase 1
24
Shanghai
2024-12-11
Not yet open
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-10
Recruiting
Ruijin Hospital
Phase 2
20
Shanghai
2024-12-10
By invitation
Yufen Wu, MD
Not applicable
35
Shanghai
2024-12-10
Recruiting
Ruijin Hospital
Phase 2
49
Shanghai
2024-12-10
Recruiting
Fudan University
Early Phase 1
38
Shanghai
2024-12-10
Recruiting
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
NCT06567353Breast Neoplasms, Liver Neoplasms, Metastasis
Ruijin Hospital
Not applicable
10
Shanghai
2024-12-09
Recruiting
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
150
Guangzhou, Shenzhen, Zhengzhou, Nanjing, Nanchang, Shanghai, Xi’an, Chengdu
2024-12-09
Recruiting
Shanghai Chest Hospital
Phase 1
19
Shanghai
2024-12-09
Recruiting
Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
NCT06717048Myopia, Refractive Error - Myopia, Choroidal Thickness, Retina
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
108
Shanghai
2024-12-09
Recruiting
Novartis Pharmaceuticals
Phase 3
60
Beijing, Shanghai
2024-12-09
Recruiting
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
130
Shanghai, Chongqing
2024-12-06
Recruiting
Efficacy and Safety of Telitacicept in IgAN
NCT06654596IgA Nephropathy (IgAN), Kidney Diseases, Telitacicept, Glucocorticoid
DrugTelitacicept
Ruijin Hospital
Not applicable
118
Shanghai
2024-12-06
Recruiting
Fudan University
Observational
120
Shanghai
2024-12-05
Recruiting
Study of SC-102 in Patients With Advanced Solid Tumors
NCT06710158Advanced Solid Cancers
Tianjin ConjuStar Biologics Co., Ltd.
Phase 1
120
Shanghai
2024-12-05
Recruiting
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT06715839Malignancy, Digestive Cancer, Digestive System Neoplasm, Digestive System Carcinoma
Drugs[18F]F-RESCA-RB14·[18F]F-RESCA-T4·[68Ga]Ga-NOTA-T4
RenJi Hospital
Not applicable
400
Shanghai
2024-12-04
Recruiting
Huashan Hospital
Not applicable
52
Shanghai
2024-12-04
Recruiting
Ruijin Hospital
Phase 2
30
Shanghai
2024-12-03
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2024-12-03
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
100
Shanghai
2024-12-01
Recruiting
Fudan University
Observational
6,000
Shanghai
2024-12-01
Recruiting
Huashan Hospital
Phase 2
40
Shanghai
2024-12-01
Not yet open
Ruijin Hospital
Phase 2
66
Shanghai
2024-12-01
Not yet open
Effects of Monitoring Blood Pressure During Pregnancy
NCT06217913Birth Weight, Weight Gain Trajectory
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
400
Shanghai
2024-12-01
Not yet open
First-line Treatment of Advanced/unresectable DDLPS
NCT06694324Dedifferentiated Liposarcoma, Soft Tissue Sarcoma (STS)
DrugsLiposomal doxorubicin·Apatinib·Camrelizumab
Fudan University
Phase 2
49
Shanghai
2024-12-01
Recruiting
RenJi Hospital
Not applicable
236
Shanghai
2024-12-01
Active, closed
Ruijin Hospital
Observational
216
Shanghai
2024-12-01
Active, closed
Real-world Study on Fenestrated Stent for Thoracic Aortic Dissection
NCT07268755Thoracic Aortic Dissection, Thoracic Aortic Disease
Qingyou Meng
Observational
320
Shanghai
2024-12-01
Recruiting
Qiang Dong
Observational
15,000
Shanghai
2024-12-01
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
100
Shanghai
2024-12-01
Recruiting
Shanghai East Hospital
Observational
40
Shanghai
2024-12-01
Not yet open
Changhai Hospital
Not applicable
204
Qinghai, Shanghai, Xi'an
2024-12-01
Active, closed
Fudan University
Not applicable
24
Shanghai
2024-12-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
382
Shanghai
2024-12-01
Recruiting
Fudan University
Observational
1,920
Shanghai
2024-12-01
By invitation
Risk Model for Metastasis Detection of Neuroblastoma
NCT06703944Neuroblastoma (NB), Prognosis, Bone Marrow Metastasis, Bone Metastases
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
500
Shanghai, Hangzhou, Shenzhen
2024-12-01
Recruiting
Changhai Hospital
Not applicable
3,000
Shanghai
2024-12-01
Not yet open
Ruijin Hospital
Phase 2
35
Shanghai
2024-12-01
Not yet open
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-01
Recruiting
Safety and Efficacy of IMPT or IMRT for Breast Cancer
NCT06826885Breast Cancer, Proton Therapy, Intensity Modulated Radiation Therapy, Efficacy and Safety
Ruijin Hospital
Observational
500
Shanghai
2024-12-01
Not yet open
Akeso
Phase 1
87
Shanghai
2024-12
Not yet open
Fudan University
Phase 2
20
Shanghai
2024-12
Not yet open
A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
NCT06724263Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers, Small Cell Lung Cancer
DrugB1962
Tasly Biopharmaceuticals Co., Ltd.
Phase 2
120
Shanghai
2024-12
Not yet open
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
NCT06728618Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC), Resectable Oral and Oropharyngeal Squamous Cell Carcinoma, Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
28
Shanghai
2024-12
Not yet open
JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC
NCT06731153Triple Negative Breast Cancer (TNBC), Metastatic Breast Cancer
DrugsIvarmacitinib·Eribulin·Camrelizumab
Fudan University
Phase 2
40
Shanghai
2024-12
Recruiting
PSA Versus STN DBS for DT
NCT06752434Dystonic Tremor
Ruijin Hospital
Not applicable
20
Shanghai
2024-12
Recruiting
Fudan University
Phase 2
100
Shanghai
2024-11-30
Not yet open
Fudan University
Phase 2
30
Shanghai
2024-11-30
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2024-11-29
Active, closed
Yibin Fang
Observational
150
Shanghai
2024-11-29
Recruiting
Huashan Hospital
Observational
484
Shanghai
2024-11-29
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
136
Shanghai, Chengdu
2024-11-28
Recruiting
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089Urologic Neoplasms, Urogenital Neoplasms, Kidney Neoplasms, Neoplasms
Drug[18F]RCCB6
RenJi Hospital
Phase 2
300
Shanghai
2024-11-27
Recruiting
Kangabio AUSTRALIA LTD PTY
Phase 1
57
Beijing, Shanghai
2024-11-27
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Chengdu, Guangzhou, Nanchang, Nanjing, Nantong, Shandong, Shanghai, Tianjin
2024-11-27
Active, closed
Liu Cheng
Observational
50
Shanghai
2024-11-26
Recruiting
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
NCT06668103Non-Small Cell Lung Cancer With EGFR Mutation
DrugsABSK043·Furmonertinib
Abbisko Therapeutics Co, Ltd
Phase 2
54
Hefei, Harbin, Wuhan, Changchun, Shanghai
2024-11-25
Recruiting
Fudan University
Phase 2/3
50
Shanghai
2024-11-22
Recruiting
Fudan University
Phase 2/3
50
Shanghai
2024-11-22
Recruiting
The Trend of Copeptin Levels and Its Clinical Value for Postoperative CDI in Pediatric Patients After NSI in ICU
NCT06742060Diabetes Insipidus, Neurohypophyseal, Copeptin Blood Levels, Copeptin, Neurosurgical Intervention
Children's Hospital of Fudan University
Observational
100
Shanghai
2024-11-22
Recruiting
A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss
NCT06722170DFNB9, Congenital Hearing Loss, Hearing Loss, Sensorineural
Yilai Shu
Not applicable
24
Zhengzhou, Shanghai
2024-11-22
Recruiting
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
NCT06666270Advanced Solid Cancer, Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Phase 1
30
Zhengzhou, Shanghai
2024-11-21
Recruiting
Shanghai Zhongshan Hospital
Phase 2
49
Shanghai
2024-11-21
Active, closed
Ruijin Hospital
Phase 2
80
Chengdu, Shanghai, Yantai
2024-11-21
Recruiting
Shanghai Chest Hospital
Phase 2
32
Shanghai
2024-11-20
By invitation
Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients
NCT07098676Healthy Individuals (Controls), Vascular Surgery Patients With Acute Thrombosis, Dialysis Patients
Ai Peng
Observational
900
Shanghai
2024-11-20
Recruiting
Ruijin Hospital
Phase 2
144
Shanghai
2024-11-20
Recruiting
Micturition Desire-Relaxation Training Device for Lower Urinary Tract Dysfunction in Children
NCT07000656Daytime Urinary Incontinence, Urinary Frequency, Lower Urinary Tract Dysfunction, Primary Nocturnal Enuresis
Shanghai Children's Medical Center
Not applicable
200
Shanghai
2024-11-20
Recruiting
A Survey on Growth Development in Children After Liver Transplantation
NCT07574398Growth, Development in Pediatric Liver Transplant Recipients
RenJi Hospital
Observational
275
Shanghai
2024-11-20
Recruiting
ImmunoPET Imaging of Pancreatic Cancer
NCT06602037Neoplasms Pancreatic
RenJi Hospital
Not applicable
90
Shanghai
2024-11-20
Recruiting
Ivonescimab in the Treatment of Multiple Advanced Tumors
NCT06683846Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma, Paget Disease, Extramammary, Renal Angiomyolipoma
Fudan University
Phase 2
400
Shanghai
2024-11-20
Recruiting
Fudan University
Phase 3
250
Shanghai
2024-11-19
Recruiting
Shanghai Zhongshan Hospital
Not applicable
45
Shanghai
2024-11-19
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
22
Shanghai
2024-11-19
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
12
Shanghai
2024-11-18
Recruiting
Evaluation of Two Cell-based Assays for Diagnosing MOG-IgG Associated Disorders
NCT06617962Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
Huashan Hospital
Observational
240
Shanghai
2024-11-18
Recruiting
Fudan University
Not applicable
9
Shanghai
2024-11-15
Active, closed
BeOne Medicines
Phase 2
94
Fuzhou, Zhengzhou, Changzhou, Nanjing, Shanghai, Hangzhou
2024-11-14
Not yet open
Sir Run Run Shaw Hospital
Phase 2
76
Fuzhou, Guangzhou, Shanghai, Hangzhou
2024-11-14
Recruiting
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase 1/2
33
Shanghai
2024-11-13
Active, closed
BioRay Pharmaceutical Co., Ltd.
Phase 2
135
Shanghai
2024-11-13
Recruiting
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
NCT07433283Tumor, Solid, Lung Cancer, Pancreas Cancer, Thyroid Cancer
Sichuan Enray Pharmaceutical Sciences Company
Phase 1/2
54
Beijing, Hunan, Chongqing, Fuzhou, Haikou, Heilongjiang, Shanghai, Chengdu
2024-11-12
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
40
Shanghai
2024-11-12
Recruiting
Akeso
Phase 2
172
Shanghai
2024-11-12
Not yet open
Shanghai University of Traditional Chinese Medicine
Observational
250
Shanghai
2024-11-12
Recruiting
Shanghai Changzheng Hospital
Early Phase 1
9
Shanghai
2024-11-12
Recruiting
Fudan University
Observational
100
Shanghai
2024-11-11
Active, closed
Shenzhen Shenxin Biotechnology Co., Ltd
Phase 1
240
Shanghai, Kunming
2024-11-11
Active, closed
GlaxoSmithKline
Phase 2
283
Beijing, Chengdu, Guangzhou, Shanghai
2024-11-11
By invitation
GCB-002 in Treatment of Patients With Rett Syndrome
NCT06739434RETT Syndrome With Proven MECP2 Mutation
Genecombio Ltd.
Not applicable
6
Shanghai
2024-11-11
Recruiting
Zhen Wang
Not applicable
40
Shanghai
2024-11-10
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2024-11-09
Recruiting
Ranok Therapeutics (Hangzhou) Co., Ltd.
Phase 1/2
152
Nanning, Zhengzhou, Wuhan, Hangzhou, Shanghai
2024-11-08
Recruiting
Shanghai Zhongshan Hospital
Phase 2
84
Shanghai
2024-11-08
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
48
Shanghai
2024-11-07
Recruiting
RenJi Hospital
Observational
358
Shanghai
2024-11-07
Recruiting
Shanghai Changzheng Hospital
Early Phase 1
9
Shanghai
2024-11-07
Recruiting
Peng Zhang
Phase 2
60
Shanghai
2024-11-07
Active, closed
Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors
NCT06849921Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors, Hematologic Disease
Ruijin Hospital
Not applicable
200
Shanghai
2024-11-07
Recruiting
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
NCT06750419Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
82
Beijing, Hangzhou, Hubei, Shanghai, Suzhou, Tianjin, Wuxi, Zhejiang
2024-11-06
Active, closed
HuidaGene Therapeutics Co., Ltd.
Early Phase 1
4
Shanghai
2024-11-06
Active, closed
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
208
Shanghai
2024-11-04
Recruiting
Fudan University
Phase 2
129
Shanghai
2024-11-04
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Hefei, Fuzhou, Xiamen, Guangzhou, Nanning, Zhengzhou, Shanghai, Taiyuan
2024-11-03
Recruiting
Shanghai Chest Hospital
Phase 2
52
Shanghai
2024-11-01
Recruiting
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
NCT06676449Esophageal Carcinoma, Radiotherapy, Immunotherapy
Fudan University
Phase 3
432
Shanghai
2024-11-01
Not yet open
Shanghai 10th People's Hospital
Not applicable
2,000
Kaifeng, Zhengzhou, Shanghai
2024-11-01
Active, closed
Cola Ingestion for Esophageal Bolus Impaction
NCT06652620Esophageal Cancer
Fudan University
Not applicable
50
Xiamen, Anyang, Yangzhou, Jingdezhen, Shanghai
2024-11-01
Recruiting
Shanghai Zhongshan Hospital
Observational
20
Shanghai
2024-11-01
Recruiting
Postoperative Pain of Robotic, Endoscopic and Open Lateral Neck Dissection
NCT06803732Pain, Postoperative, Thyroid Diseases, Surgery
Shanghai 6th People's Hospital
Observational
600
Shanghai
2024-11-01
Recruiting
Fudan University
Phase 2
340
Shanghai
2024-11-01
Recruiting
Fudan University
Phase 2
80
Shanghai
2024-11-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Observational
50
Shanghai
2024-11-01
Not yet open
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
NCT06641024Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia
DrugMC-1-50
Chongqing Precision Biotech Co., Ltd
Phase 1
24
Shanghai
2024-11-01
Recruiting
Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
NCT06994221Acute Myocardial Infarction, Ventricular Aneurysm Following Acute Myocardial Infarction, Myocardial Fibrosis
RenJi Hospital
Observational
20
Shanghai
2024-11-01
By invitation
Shanghai Chest Hospital
Observational
500
Shanghai
2024-11-01
Active, closed
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2024-11-01
Recruiting
Shanghai Jiao Tong University School of Medicine
Phase 2
48
Shanghai
2024-11-01
Recruiting
Fudan University
Phase 2
340
Shanghai
2024-11-01
Not yet open
Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06704542ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Diabetes Mellitus, Impaired Fasting Glucose
Ruijin Hospital
Observational
1,000
Zhengzhou, Wuhan, Shanghai, Hangzhou, Tianjin
2024-11
Not yet open
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
120
Beijing, Nanning, Zhengzhou, Shanghai, Hangzhou
2024-11
Recruiting
Fudan University
Phase 2
22
Shanghai
2024-10-31
Recruiting
Brii Biosciences Limited
Phase 2
250
Beijing, Guangzhou, Shenzhen, Shanghai, Chengdu, Hangzhou
2024-10-31
Recruiting
Innolake Biopharm
Phase 1
240
Shanghai
2024-10-30
Recruiting
Hansoh BioMedical R&D Company
Phase 1
450
Shanghai
2024-10-30
Recruiting
Shanghai Zhongshan Hospital
Observational
1,516
Shanghai
2024-10-30
Active, closed
Shanghai Jiao Tong University School of Medicine
Phase 2
47
Shanghai
2024-10-30
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
59
Shanghai
2024-10-30
Active, closed
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
NCT06762158Esophageal Squamous Cell Carcinoma (ESCC)
RenJi Hospital
Not applicable
50
Shanghai
2024-10-30
Recruiting
Multicenter iTBS Neuromodulation for PTSD Treatment
NCT06434766Posttraumatic Stress Disorder
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
140
Shanghai, Hangzhou, Ningbo
2024-10-30
Not yet open
RenJi Hospital
Phase 2
104
Shanghai
2024-10-30
Not yet open
Ruijin Hospital
Observational
200
Shanghai
2024-10-30
Not yet open
Ruijin Hospital
Phase 2
218
Shanghai
2024-10-30
Active, closed
Daiichi Sankyo
Phase 1/2
137
Changchun, Hangzhou, Harbin, Jiamusi, Shanghai, Tiyuan, Zhengzhou
2024-10-30
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
DrugGuselkumab
Janssen Research & Development, LLC
Phase 3
196
Beijing, Changzhou, Hangzhou, Shanghai, Shenyang
2024-10-29
Recruiting
Hangzhou Adcoris Biopharmacy Co., Ltd
Phase 1
77
Beijing, Zhejiang, Shandong, Shanghai
2024-10-29
Active, closed
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
9
Shanghai
2024-10-28
Active, closed
Shanghai Jiao Tong University School of Medicine
Phase 1/2
9
Shanghai
2024-10-28
Active, closed
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
24
Shanghai
2024-10-28
Recruiting
Ruijin Hospital
Observational
35
Shanghai
2024-10-25
Recruiting
Shanghai 6th People's Hospital
Not applicable
150
Shanghai
2024-10-25
Recruiting
Shanghai Jiao Tong University School of Medicine
Early Phase 1
12
Shanghai
2024-10-24
Recruiting
Shanghai Zhongshan Hospital
Phase 2
100
Shantou, Shenyang, Shanghai, Tianjin, Hangzhou
2024-10-24
Recruiting
Fudan University
Phase 2
33
Shanghai
2024-10-24
Recruiting
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
NCT06379646Systemic Lupus Erythematosus, Systemic Sclerosis, Inflammatory Myopathy, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
China Immunotech (Beijing) Biotechnology Co., Ltd.
Not applicable
6
Shanghai
2024-10-24
Active, closed
A Study of Single Dose of LP-003 in Healthy Adult Subjects
NCT06604949Chronic Spontaneous Urticaria
DrugLP-003
Longbio Pharma
Phase 1
12
Shanghai
2024-10-23
Recruiting
Huashan Hospital
Phase 3
144
Shanghai
2024-10-23
Recruiting
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT06649331Advanced Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer (TNBC), HER2-negative Breast Cancer
DrugsSHR-A1921·SHR-A2009·Famitinib·9MW2821
Fudan University
Phase 2
160
Shanghai
2024-10-21
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2024-10-20
Active, closed
Akeso
Phase 3
682
Harbin, Shanghai
2024-10-20
Recruiting
Ruijin Hospital
Observational
50
Shanghai
2024-10-19
Active, closed
Servier
Phase 3
57
Shenzhen, Chengdu, Beijing, Shanghai, Xi'an
2024-10-18
Recruiting
Fudan University
Phase 4
756
Harbin, Changzhou, Nanjing, Yangzhou, Shanghai, Hangzhou, Ningbo
2024-10-18
Active, closed
Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.
NCT07274761Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer
DrugSunvozertinib
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
24
Shanghai
2024-10-17
Recruiting
Shanghai Ruiliyuan Biotechnology Co., Ltd.
Phase 1
12
Shanghai
2024-10-17
Active, closed
GlaxoSmithKline
Phase 2
23
Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Kunming, Shanghai
2024-10-17
Active, closed
Fudan University
Not applicable
40
Shanghai
2024-10-16
Recruiting
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
12
Shanghai, Hangzhou
2024-10-16
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
20
Shanghai
2024-10-16
Active, closed
Fudan University
Not applicable
40
Shanghai
2024-10-16
Recruiting
Fudan University
Not applicable
40
Shanghai
2024-10-16
Recruiting
RenJi Hospital
Phase 4
40
Shanghai
2024-10-16
Recruiting
Yan Hongli
Phase 1/2
50
Shanghai
2024-10-15
Recruiting
Ruijin Hospital
Observational
40
Shanghai
2024-10-15
Recruiting
Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
NCT06241482Neurocritical Care, Traumatic Brain Injury, Cerebrovascular Disease, Moderate or Severe Coma
Shanghai 6th People's Hospital
Not applicable
80
Shanghai
2024-10-15
Recruiting
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
NCT07031661High-risk, Bipolar Disorder, Atypical Depression
Shanghai Mental Health Center
Observational
1,200
Shanghai
2024-10-15
Recruiting
A Phase Ib Study of GC101 in NSCLC
NCT06473961Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer
DrugAutologous Tumor Infiltrating Lymphocytes
Shanghai Juncell Therapeutics
Phase 1
20
Shanghai
2024-10-14
Recruiting
Fudan University
Phase 2
160
Shanghai
2024-10-14
Recruiting
Shanghai Chest Hospital
Phase 2
52
Shanghai
2024-10-13
Recruiting
Shanghai Changzheng Hospital
Early Phase 1
37
Shanghai
2024-10-12
Recruiting
Changhai Hospital
Not applicable
80
Shanghai
2024-10-12
Recruiting
Shanghai Zhongshan Hospital
Not applicable
40
Shanghai
2024-10-12
Recruiting
MRI Performance and Risk Factors in Bilateral Vestibular Hypofunction
NCT07709143Bilateral Vestibular Hypofunction, Bilateral Vestibulopathy, Presbyvestibulopathy
Shanghai 6th People's Hospital
Observational
120
Shanghai
2024-10-11
Recruiting
Boehringer Ingelheim
Phase 2
588
Beijing, Changsha, Hangzhou, Hefei, Nanchang, Nanjing, Shanghai, Wuhan
2024-10-11
Recruiting
Shanghai Proton and Heavy Ion Center
Not applicable
312
Shanghai
2024-10-10
Recruiting
ShanghaiTech University
Not applicable
6
Shanghai
2024-10-10
Active, closed
Jenscare Scientific
Not applicable
126
Shanghai
2024-10-09
Not yet open
RenJi Hospital
Not applicable
18
Shanghai
2024-10-09
Recruiting
Shanghai Changzheng Hospital
Observational
150
Shanghai
2024-10-09
Recruiting
First Affiliated Hospital of Zhejiang University
Phase 2
35
Nanchang, Hangzhou, Harbin, Hefei, Jinhua, Nantong, Shanghai, Shanxi
2024-10-09
Recruiting
Fudan University
Phase 2
60
Shanghai
2024-10-09
Recruiting
LaNova Medicines Limited
Phase 1/2
108
Xinxiang, Liaocheng, Zibo, Shanghai
2024-10-09
Active, closed
Shanghai Changzheng Hospital
Observational
120
Shanghai
2024-10-08
Recruiting
Amgen
Phase 1
220
Changchun, Shanghai
2024-10-07
Recruiting
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NCT06632886Lung Cancers, Liver Cancer, Gastric Cancers, Colorectal, Cancer
Guo ShiWei
Not applicable
1,000,000
Shanghai
2024-10-07
Recruiting
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
201
Shanghai
2024-10-04
Active, closed
Shanghai 10th People's Hospital
Not applicable
30
Shanghai
2024-10-01
Active, closed
Clinical and Mechanistic Research on Autogenous Arteriovenous Fistula in Hemodialysis Patients
NCT07058441Arteriovenous Fistula Maturation Failure in End-stage Renal Disease
Ai Peng
Observational
100
Shanghai
2024-10-01
Recruiting
Jialei Wang
Phase 2
60
Shanghai
2024-10-01
Recruiting
AI-Empowered Fundus Platform
NCT07424755High Myopia
Shanghai 10th People's Hospital
Observational
1,000
Shanghai
2024-10-01
Recruiting
Children's Hospital of Fudan University
Observational
200
Shanghai
2024-10-01
By invitation
Ruijin Hospital
Observational
266
Shanghai
2024-10-01
By invitation
Shanghai Zhongshan Hospital
Observational
107
Shanghai
2024-10-01
Not yet open
Fudan University
Phase 1/2
58
Shanghai
2024-10-01
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
44
Shanghai
2024-10-01
Active, closed
Ruijin Hospital
Not applicable
205
Shanghai
2024-10-01
Recruiting
Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
NCT07492693Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
DrugHetrombopag
Changhai Hospital
Phase 2
40
Shanghai
2024-10-01
Active, closed
Shanghai AbelZeta Ltd.
Phase 1/2
121
Shanghai, Hanzhou
2024-09-30
Not yet open
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
296
Shanghai
2024-09-30
Active, closed
Fudan University
Phase 2
20
Shanghai
2024-09-30
Recruiting
Fudan University
Observational
800
Shanghai
2024-09-30
Recruiting
Fudan University
Phase 2
130
Shanghai
2024-09-30
Recruiting
Fudan University
Phase 2
116
Shanghai
2024-09-30
Active, closed
Pulsed-Field Ablation With/Without Electrogram Mapping
NCT07541989Non-paroxysmal Atrial Fibrillation
Xu Liu
Not applicable
300
Wuhan, Changshu, Xuzhou, Jinan, Wenling, Yuhuan, Shanghai
2024-09-30
Recruiting
Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
NCT05613452Non-small Cell Lung Cancer
Shanghai Proton and Heavy Ion Center
Phase 2
43
Shanghai
2024-09-29
Recruiting
Bactiseal Catheter Safety Registry Study
NCT06276543Hydrocephalus
Integra LifeSciences Corporation
Observational
200
Beijing, Guangzhou, Harbin, Wuhan, Shanghai, Chengdu
2024-09-29
Recruiting
Shanghai Institute Of Biological Products
Phase 2
81
Shanghai
2024-09-27
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Zhenjiang, Xi'an, Shanghai
2024-09-26
Recruiting
Neck Observation or Elective Neck Dissection in cT1N0M0 OSCC
NCT06623266Oral Cancer, Lymph Node Metastasis
Huashan Hospital
Not applicable
300
Shanghai
2024-09-26
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
100
Harbin, Shanghai
2024-09-25
Recruiting
Children's Cancer Group, China
Phase 2/3
96
Shanghai
2024-09-25
Recruiting
Magnetoencephalography in Children
NCT06668519Epilepsy, Intracranial Tumors, Cerebrovascular Disease, Autism
Children's Hospital of Fudan University
Observational
1,500
Shanghai
2024-09-25
Not yet open
TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor
NCT06619886Solid Tumor, Adult, Lung Adenocarcinoma, Pancreas Cancer, Colorectal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early Phase 1
9
Shanghai
2024-09-24
Recruiting
Ruijin Hospital
Early Phase 1
56
Shanghai
2024-09-24
Recruiting
Ruijin Hospital
Observational
30
Shanghai
2024-09-24
Recruiting
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
NCT06569758Safety, Tolerability, GenSci098, Thyroid Eye Disease (TED)
DrugGenSci098
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
76
Shanghai
2024-09-24
Recruiting
Functional IOL Implantation in Patients With Epiretinal Membrane
NCT06719739Cataract, Intraocular Lens Complication, Epiretinal Membrane
Eye & ENT Hospital of Fudan University
Not applicable
90
Shanghai
2024-09-21
Recruiting
Combination of TURP and Standard Systemic Therapy for MPCa
NCT06655259Metastatic Prostate Cancer
Fudan University
Phase 2
200
Shanghai
2024-09-21
Recruiting
The Efficacy of Allo-HSCT in ND HR-CBF-AML
NCT06458244Acute Myeloid Leukemia
Ruijin Hospital
Observational
90
Shanghai
2024-09-21
Recruiting
Target-specific immunoPET Imaging of Breast Cancer
NCT06715826Breast Cancer, Breast Neoplasms, Breast Cancer Metastatic
Drugs[18F]F-RESCA-RB14·[18F]F-RESCA-RT4
RenJi Hospital
Phase 1/2
200
Shanghai
2024-09-21
Active, closed
EGM Guided PFA for PerAF
NCT06729866Persistent Atrial Fibrillation
Xu Liu
Not applicable
58
Shanghai
2024-09-20
Not yet open
Shanghai Zhongshan Hospital
Phase 2
54
Shanghai
2024-09-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
160
Beijing, Fuzhou, Xiamen, Zhengzhou, Nanchang, Shanghai, Ürümqi, Hangzhou
2024-09-20
Recruiting
U87 CAR-T in Patients With Advanced Head and Neck Tumors
NCT06614686Nasopharynx Cancer, Head and Neck Cancer
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1
20
Shanghai
2024-09-20
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
30
Shanghai
2024-09-19
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Beijing, Chengdu, Shanghai
2024-09-19
Recruiting
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
33
Beijing, Nanchang, Shanghai, Suzhou, Wuhan, Xuzhou
2024-09-19
Recruiting
Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)
NCT06726421Renal Cell Carcinoma (Kidney Cancer), Kidney Cancer Metastatic, Renal Cell Carcinoma Metastatic
Sun Yat-sen University
Phase 3
252
Fuzhou, Guangzhou, Wuhan, Changchun, Chengdu, Wenzhou, Beijing, Shanghai
2024-09-18
Active, closed
argenx
Phase 3
141
Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Jinan, Nanchang, Shanghai
2024-09-18
Recruiting
AstraZeneca
Phase 1/2
174
Hangzhou, Shanghai
2024-09-18
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
Hefei, Beijing, Guangzhou, Shenzhen, Shijiazhuang, Nanchang, Pudong, Shanghai
2024-09-17
Active, closed
Dianthus Therapeutics
Phase 2
46
Beijing, Shanghai
2024-09-17
Recruiting
Pierre Fabre Medicament
Phase 1/2
171
Shanghai, Tianjin
2024-09-17
Active, closed
Evaluation on Visual Outcome of TMS
NCT06612190Visual Impairment
Evidence Based Cataract Study Group
Not applicable
300
Shanghai
2024-09-15
Recruiting
A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty
NCT06510764Precocious Puberty, Treatment, Alternative Medicine, Acupuncture
Children's Hospital of Fudan University
Phase 3
170
Shanghai
2024-09-15
Recruiting
Fudan University
Phase 2
76
Shanghai
2024-09-14
Recruiting
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
60
Shanghai
2024-09-14
Recruiting
FeNO Detection in Asthma Diagnosis: A New Technology Approach
NCT06852911Bronchial Asthma, Airway Disease
Novlead Inc.
Not applicable
170
Shanghai, Wuxi
2024-09-12
By invitation
Cutia Therapeutics（Wuxi）Co.,Ltd
Phase 1
64
Shanghai
2024-09-12
By invitation
Eye & ENT Hospital of Fudan University
Observational
60
Shanghai
2024-09-12
Recruiting
Shanghai Chest Hospital
Phase 3
478
Shanghai
2024-09-12
Active, closed
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
NCT06586515Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer
DrugsLeucovorin·Irinotecan·Cetuximab·Adrucil
Eli Lilly and Company
Phase 1
630
Beijing, Harbin, Shanghai
2024-09-12
Recruiting
First Affiliated Hospital of Zhejiang University
Not applicable
99
Hefei, Fuzhou, Quanzhou, Xiamen, Zhangzhou, Shanghai, Hangzhou
2024-09-11
Recruiting
GlaxoSmithKline
Phase 3
440
Beijing, Chengdu, Guangzhou, Hangzhou, Mianyang, Nanjing, Nanning, Shanghai
2024-09-11
Active, closed
Fudan University
Phase 2
50
Shanghai
2024-09-10
Recruiting
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3
420
Beijing, Shanghai
2024-09-10
Recruiting
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-09-07
Recruiting
Pinoxin for the Prevention of Radiation-Induced Skin Injury
NCT07545720Cancer Patients Undergoning Radiotherapy
Fudan University
Phase 2
202
Shanghai
2024-09-05
Recruiting
Fudan University
Observational
600
Shanghai
2024-09-05
Active, closed
Takeda
Phase 3
2,099
Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Wuhan, Zhenjiang, Shanghai
2024-09-04
Recruiting
Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
NCT06484985Non-Hodgkin Lymphoma, Advanced Solid Tumor
Axter Therapeutics (Beijing) Co., Ltd
Phase 1
78
Beijing, Changsha, Fuzhou, Guangzhou, Shanghai
2024-09-04
Recruiting
Wayshine Biopharm, Inc.
Phase 1/2
100
Hefei, Beijing, Guangzhou, Zhengzhou, Jinan, Shanghai, Chengdu, Tianjin
2024-09-04
Active, closed
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 3
72
Beijing, Chongqing, Guangzhou, Changsha, Nanjing, Qingdao, Shanghai, Xi’an
2024-09-03
Recruiting
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
130
Shanghai
2024-09-03
Recruiting
Ruijin Hospital
Observational
300
Shanghai
2024-09-02
Recruiting
Changhai Hospital
Not applicable
194
Shanghai
2024-09-02
Active, closed
Shanghai Vitalgen BioPharma Co., Ltd.
Phase 1/2
39
Shanghai
2024-09-02
Recruiting
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
265
Shanghai
2024-09-02
Not yet open
Shanghai Chest Hospital
Not applicable
134
Wuhan, Nanchang, Shanghai, Ürümqi, Wenzhou
2024-09-01
Recruiting
Changhai Hospital
Not applicable
20
Shanghai
2024-09-01
Recruiting
Children's Hospital of Fudan University
Not applicable
150
Shanghai
2024-09-01
Active, closed
Diet Intervention on Obesity Related Complication
NCT06719466Obese, Stomach Diseases
Zhang Manna
Not applicable
30
Shanghai
2024-09-01
Not yet open
Fudan University
Phase 2
30
Shanghai
2024-09-01
Recruiting
Tang-Du Hospital
Not applicable
96
Wuhan, Nanjing, Shenyang, Xi'an, Chengdu, Ürümqi, Chongqing, Shanghai
2024-09-01
Recruiting
Jiayuan Sun
Not applicable
110
Guangzhou, Zhengzhou, Shanghai, Chengdu, Hangzhou
2024-09-01
Recruiting
RenJi Hospital
Not applicable
104
Shanghai
2024-09-01
Active, closed
Zhimin Shao
Phase 3
307
Shanghai
2024-09-01
Recruiting
Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes
NCT04532346Interstitial Lung Disease, Surfactant Dysfunction
DrugHydroxychloroquine
Children's Hospital of Fudan University
Early Phase 1
60
Shanghai
2024-09-01
Recruiting
Magnetic Seizure Therapy for Psychotic Disorders
NCT06581302Psychotic Disorders
Shanghai Jiao Tong University School of Medicine
Not applicable
50
Shanghai
2024-09-01
Recruiting
Shanghai Changzheng Hospital
Phase 2
75
Shanghai
2024-09-01
Not yet open
JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases
NCT06567080B-cell Tumors, Autoimmune Diseases, Lupus Erythematosus, Systemic, Large B-cell Lymphoma
DrugJWCAR201
RenJi Hospital
Phase 1
15
Shanghai
2024-09
Not yet open
Fudan University
Phase 2
242
Shanghai
2024-09
Not yet open
Ruijin Hospital
Phase 2
45
Shanghai
2024-09
Not yet open
Fudan University
Phase 2
94
Shanghai
2024-08-31
Not yet open
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
144
Shanghai
2024-08-31
Recruiting
AR Training Versus Patching in Unilateral Amblyopia
NCT06498206Amblyopia Unilateral
Eye & ENT Hospital of Fudan University
Not applicable
114
Shanghai
2024-08-31
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
48
Beijing, Harbin, Zhengzhou, Shenyang, Jinan, Shanghai, Hangzhou
2024-08-31
Recruiting
Children's Hospital of Fudan University
Not applicable
1,600
Shanghai
2024-08-30
Recruiting
Study With [225Ac]Ac-FL-020 in mCRPC Participants
NCT06492122Metastatic Castration-resistant Prostate Cancer
DrugBlood samples for PK
Full-Life Technologies UK Limited
Phase 1
50
Beijing, Shanghai
2024-08-30
Recruiting
Kunwei Shen
Observational
150
Shanghai
2024-08-30
Recruiting
ShangHai Ji Ai Genetics & IVF Institute
Not applicable
208
Shanghai
2024-08-30
Recruiting
Xiamen Amoytop Biotech Co., Ltd.
Phase 2
27
Beijing, Fujian, Guangzhou, Harbin, Henan, Shanghai, Zhejiang
2024-08-29
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
Observational
1,430
Shanghai
2024-08-28
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
21
Shanghai
2024-08-26
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
20
Harbin, Shanghai
2024-08-24
Recruiting
Shanghai Mental Health Center
Observational
125
Shanghai
2024-08-24
Recruiting
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3
460
Shanghai
2024-08-22
By invitation
Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
NCT06712017Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable
GrandPharma (China) Co., Ltd.
Observational
100
Guangzhou, Jinan, Xi’an, Beijing, Shanghai
2024-08-22
Active, closed
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1/2
20
Shanghai, Wuhan
2024-08-22
Recruiting
Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
NCT07399210Lung Cancer (Diagnosis), Fragmentomics
Baohui Han
Observational
240
Shanghai
2024-08-21
Active, closed
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3
211
Shanghai
2024-08-21
Not yet open
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
80
Shanghai
2024-08-19
Recruiting
Fudan University
Phase 4
60
Shanghai
2024-08-19
By invitation
Shanghai Chest Hospital
Observational
500
Shanghai
2024-08-16
Active, closed
Novel Lenses for Myopia Progression Trial
NCT06563700Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
342
Shanghai
2024-08-16
By invitation
Evaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease
NCT06518681Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Regurgitation
Suzhou Hearthill Medical Technology Co.,LTD
Not applicable
10
Shanghai
2024-08-15
Not yet open
OXiris for Abdominal SEptic Shock (OASES Study)
NCT06504316Septic Shock, Abdominal Sepsis, Multi Organ Failure, Blood Purification
RenJi Hospital
Not applicable
192
Shanghai
2024-08-15
Recruiting
Shanghai 6th People's Hospital
Observational
75
Shanghai
2024-08-15
Recruiting
Fudan University
Phase 2
36
Shanghai
2024-08-15
Recruiting
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1
400
Harbin, Shanghai
2024-08-15
Recruiting
RenJi Hospital
Observational
50
Shanghai
2024-08-15
Active, closed
Medication Adherence to Phone-supervised Pancreatic Enzyme Replacement Therapy
NCT06581653Chronic Pancreatitis, Pancreatic Exocrine Insufficiency
Changhai Hospital
Not applicable
204
Shanghai
2024-08-15
Recruiting
One-Month DAPT in CABG Patients
NCT05997693Chronic Coronary Disease
DrugsTicagrelor·Aspirin
Weill Medical College of Cornell University
Phase 3
700
Shanghai, Changchun, Beijing
2024-08-15
Active, closed
Chipscreen Biosciences, Ltd.
Phase 2
42
Shanghai
2024-08-13
Recruiting
Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
NCT06553053Crohn's Disease Relapse, Inflammatory Bowel Diseases
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
106
Shanghai
2024-08-13
Active, closed
Bolt CSP-M Holter Study
NCT06540521Heart Failure, Bradycardia
Medtronic Cardiac Rhythm and Heart Failure
Observational
95
Shanghai, Hangzhou
2024-08-13
Recruiting
Fudan University
Phase 2
46
Shanghai
2024-08-13
Recruiting
DK Medical Technology (Suzhou) Co., Ltd.
Not applicable
140
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Shanghai
2024-08-13
Not yet open
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4
90
Shanghai
2024-08-12
Recruiting
Fudan University
Phase 2
25
Shanghai
2024-08-12
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
528
Shanghai
2024-08-12
Recruiting
Efficacy and Safety of Rifaximin in Treating MAFLD
NCT07185932Metabolic-associated Fatty Liver Disease
DrugRifaximin
Shanghai Changzheng Hospital
Early Phase 1
40
Shanghai
2024-08-10
Recruiting
Huashan Hospital
Observational
300
Shanghai
2024-08-10
Active, closed
Xia Peng
Observational
174
Shanghai
2024-08-10
Not yet open
RenJi Hospital
Phase 2
80
Shanghai
2024-08-10
Active, closed
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 3
350
Shanghai
2024-08-09
Recruiting
Ascentage Pharma Group Inc.
Phase 1/2
40
Shanghai
2024-08-09
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
118
Shanghai
2024-08-09
Recruiting
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
NCT06311981Non-small Cell Lung Cancer, Older People, Carbon Ion Radiotherapy, Radiotherapy Side Effect
Jian Chen
Phase 2
29
Shanghai
2024-08-08
Active, closed
AbbVie
Phase 3
111
Beijing, Guangzhou, Zhengzhou, Changsha, Nanchang, Shenyang, Shanghai, Hangzhou
2024-08-08
Recruiting
Huashan Hospital
Not applicable
830
Shanghai
2024-08-08
Active, closed
Fudan University
Phase 2
40
Shanghai
2024-08-07
Recruiting
BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.
NCT06598722Lymphoblastic Lymphoma, Adult, Lymphoblastic Leukemia, Acute T-cell
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
206
Shanghai
2024-08-07
Active, closed
Pfizer
Observational
450
Beijing, Changchun, Changsha, Guangzhou, Shanghai
2024-08-07
Recruiting
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT06445972Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
DrugsPatritumab deruxtecan·Ramucirumab·Sacituzumab tirumotecan·Paclitaxel
Merck Sharp & Dohme LLC
Phase 1/2
210
Beijing, Fuzhou, Xiamen, Zhengzhou, Nanchang, Shanghai, Ürümqi, Hangzhou
2024-08-07
Recruiting
Changhai Hospital
Phase 3
770
Shanghai
2024-08-06
Recruiting
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1
170
Changsha, Fuzhou, Hangzhou, Kunming, Shanghai, Wuhan
2024-08-06
Active, closed
RenJi Hospital
Not applicable
12
Shanghai
2024-08-06
Recruiting
Shanghai Henlius Biotech
Phase 2
117
Shanghai
2024-08-05
Recruiting
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
NCT06638866Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraepithelial Neoplasias, Intraductal Papillary Mucinous Neoplasm
Changhai Hospital
Observational
5,000
Shanghai, Jiaxing, Ningbo
2024-08-03
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
52
Shanghai
2024-08-02
Recruiting
Biokin (Shanghai) Biopharmaceutical Co., Ltd.
Phase 1
115
Shanghai
2024-08-02
Recruiting
Ruijin Hospital
Observational
500
Shanghai
2024-08-02
Recruiting
Ruijin Hospital
Not applicable
360
Shanghai
2024-08-01
Recruiting
Shanghai Proton and Heavy Ion Center
Phase 2
780
Shanghai
2024-08-01
Recruiting
Zhangjie Yu
Observational
305
Shanghai
2024-08-01
Not yet open
RenJi Hospital
Phase 2
143
Shanghai
2024-08-01
Recruiting
Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients
NCT06566898Pneumonia, Next-generation Sequencing, Microbiome, Antimicrobial Resistance
Shanghai General Hospital, China
Observational
800
Shanghai
2024-08-01
Recruiting
Shanghai Zhongshan Hospital
Observational
50
Shanghai
2024-08-01
Recruiting
Sun Yat-sen University
Phase 2
42
Guangzhou, Shanghai
2024-08-01
Recruiting
Effectiveness of MST Versus ECT for Major Depressive Episode
NCT06409325Major Depressive Disorder (MDD)
Shanghai Mental Health Center
Not applicable
210
Shanghai
2024-08-01
Recruiting
RenJi Hospital
Not applicable
1,115
Shanghai
2024-08-01
Recruiting
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
40
Shanghai
2024-08-01
Active, closed
Shanghai Jiao Tong University School of Medicine
Early Phase 1
3
Shanghai
2024-08-01
Not yet open
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
230
Shanghai
2024-08
Recruiting
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2024-07-31
Recruiting
Fudan University
Phase 1
42
Shanghai
2024-07-31
Recruiting
Phase 2 Study of WGI-0301 for Advanced HCC
NCT06309485Advanced Hepatocellular Carcinoma (HCC)
Zhejiang Haichang Biotech Co., Ltd.
Phase 2
60
Shanghai, Changsha, Chengdu, Hangzhou, Harbin, Nanchang, Wuhan
2024-07-31
Active, closed
Shanghai Mental Health Center
Not applicable
54
Shanghai
2024-07-31
Active, closed
Shanghai Zhongshan Hospital
Observational
200
Shanghai
2024-07-31
Active, closed
magAssist, Inc.
Not applicable
236
Beijing, Changsha, Guangzhou, Hangzhou, Harbin, Lanzhou, Shanghai, Taiyuan
2024-07-31
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
76
Shanghai
2024-07-31
Recruiting
Efficacy of Two HMOs in Chinese Infants
NCT06361719Healthy Infants
Société des Produits Nestlé (SPN)
Not applicable
262
Shanghai
2024-07-29
Recruiting
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
116
Beijing, Nanning, Wuhan, Nanjing, Suzhou, Xuzhou, Nanchang, Shanghai
2024-07-29
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
300
Shanghai
2024-07-29
Recruiting
Ruijin Hospital
Phase 3
100
Shanghai
2024-07-29
Recruiting
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 2
160
Shanghai
2024-07-26
Recruiting
Zhen Wang
Not applicable
70
Shanghai
2024-07-26
Recruiting
Shanghai Jiao Tong University School of Medicine
Early Phase 1
6
Shanghai
2024-07-25
Recruiting
Lepu Biopharma Co., Ltd.
Phase 1/2
343
Beijing, Shanghai
2024-07-24
Recruiting
Yu Wang
Phase 2
14
Shanghai
2024-07-24
Rows per page Showing 2001–2500 of 3879
Previous 3 4 5 6 7 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=5

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,879 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,418 of the 3,879 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 756 have not yet opened recruitment, 598 are active but closed to new participants, and 107 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.